Page last updated: 2024-10-29

iofetamine and Basal Ganglia Diseases

iofetamine has been researched along with Basal Ganglia Diseases in 2 studies

Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.

Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamei, H1
Nakajima, T1
Fukuhara, N1
Okuda, B1
Tachibana, H1
Takeda, M1
Kawabata, K1
Sugita, M1
Fukuchi, M1

Other Studies

2 other studies available for iofetamine and Basal Ganglia Diseases

ArticleYear
[Statistic rCBF study of extrapyramidal disorders].
    No to shinkei = Brain and nerve, 2002, Volume: 54, Issue:8

    Topics: Aged; Basal Ganglia Diseases; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans;

2002
Focal cortical hypoperfusion in corticobasal degeneration demonstrated by three-dimensional surface display with 123I-IMP: a possible cause of apraxia.
    Neuroradiology, 1995, Volume: 37, Issue:8

    Topics: Aged; Amphetamines; Basal Ganglia; Basal Ganglia Diseases; Brain Ischemia; Cerebral Cortex; Diagnosi

1995